Torrent Pharmaceuticals Ltd. — M&A Activity 2025

Oct 21, 2025

==> picture [94 x 31] intentionally omitted <==

21[st] October, 2025

The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., Exchange Plaza, 5[th] 1[st] Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 Mumbai – 400 051 (BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM)

Dear Sir,

Sub: Disclosure under Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Further, to the Media Release titled "Torrent Pharma to acquire controlling stake in J. B. Chemicals & Pharmaceuticals from KKR” dated 29[th] June 2025 and Stock exchange intimation dated 3[rd] July, 2025 and 23[rd] September, 2025, this is to inform you that the Competition Commission of India (“ CCI ”) has granted its approval for the transaction on 21[st] October, 2025, subject to the parties complying with voluntary modifications to be outlined in CCI’s final order.

Thanking you,

Yours sincerely,

For TORRENT PHARMACEUTICALS LIMITED

CHINTAN Digitally signed by CHINTAN M TRIVEDI M TRIVEDI Date: 2025.10.21 22:32:01 +05'30'

CHINTAN M. TRIVEDI COMPANY SECRETARY

_________________ TORRENT PHARMACEUTICALS LIMITED

CIN: L24230GJ1972PLC002126

Reg.Office : Torrent House, Off Ashram Road, Ahmedabad- 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100, www.torrentpharma.com, Email : InvestorServices@TorrentPharma.com